{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T01:46:51Z","timestamp":1720662411832},"reference-count":64,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2205,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Cardiol"],"DOI":"10.1002\/clc.4960281306","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T12:24:26Z","timestamp":1278505466000},"page":"28-37","source":"Crossref","is-referenced-by-count":5,"special_numbering":"supplement S1","title":["Practical algorithms for pharmacologic management of the post myocardial infarction patient"],"prefix":"10.1002","volume":"28","author":[{"given":"James A.","family":"Reiffel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,18]]},"reference":[{"key":"10.1002\/clc.4960281306-BIB1|cit1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.0000134791.68010.FA","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"10.1002\/clc.4960281306-BIB2|cit2","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.1988.03410140100032","article-title":"Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction","volume":"260","author":"Yusuf","year":"1988","journal-title":"J Am Med Assoc"},{"key":"10.1002\/clc.4960281306-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB4|cit4","first-page":"389","article-title":"Coumadin Aspirin Reinfarction Study (CARS) Investigators","volume":"350","author":"Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction.","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB5|cit5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival And Ventricular Enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group","volume":"333","author":"Kober","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB7|cit7","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","volume":"342","author":"AIRE Study Investigators","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB8|cit8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1056\/NEJM200003093421023","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators (published errata appear","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB8.2|cit9","first-page":"1376","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB8.3|cit10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB9|cit11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB10|cit12","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin-converting-enzyme inhibition in stable coronary artery disease","volume":"351","author":"Braunwald","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB11|cit13","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJM199711273372201","article-title":"Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators","volume":"337","author":"Bigger","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB12|cit14","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB13|cit15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB14|cit16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0002-9149(02)02767-4","article-title":"Impact of ramipril versus other angiotensin-converting enzyme inhibitors on outcome of unselected patients with ST-elevation acute myocardial infarction","volume":"90","author":"Wienbergen","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1002\/clc.4960281306-BIB15|cit17","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group","volume":"333","author":"Kober","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB16|cit18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0002-8703(96)90559-1","article-title":"Angiotensin-converting enzyme inhibition after myocardial infarction: The Trandolapril Cardiac Evaluation Study","volume":"132","author":"Torp-Pedersen","year":"1996","journal-title":"Am Heart J"},{"key":"10.1002\/clc.4960281306-BIB17|cit19","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB18|cit20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high- risk patients after acute myocardial infarction: The OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB19|cit21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB20|cit22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB21|cit23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB22|cit24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/01.HYP.0000040264.15961.48","article-title":"ACE inhibition versus angiotensin type 1 receptor antagonism: Differential effects on PAI-1 over time","volume":"40","author":"Brown","year":"2002","journal-title":"Hypertension"},{"key":"10.1002\/clc.4960281306-BIB23|cit25","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB24|cit26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM198510243131705","article-title":"Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction","volume":"313","author":"Pedersen","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB25|cit27","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results","volume":"247","author":"Beta-Blocker Heart Attack Trial Research Group","year":"1982","journal-title":"J Am Med Assoc"},{"key":"10.1002\/clc.4960281306-BIB26|cit28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.CIR.73.3.503","article-title":"Effect of propranolol after acute myocardial infarction in patients with congestive heart failure","volume":"73","author":"Chadda","year":"1986","journal-title":"Circulation"},{"key":"10.1002\/clc.4960281306-BIB27|cit29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1388-9842(00)00100-8","article-title":"Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials","volume":"2","author":"Houghton","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"10.1002\/clc.4960281306-BIB28|cit30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7326\/0003-4819-118-2-199301150-00004","article-title":"Beta-blockers after myocardial infarction: Influence of first-year clinical course on long-term effectiveness","volume":"118","author":"Viscoli","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1002\/clc.4960281306-BIB29|cit31","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial","volume":"357","author":"CAPRICORN Investigators","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB30|cit32","first-page":"II","article-title":"Carvedilol reduces supraventricular and ventricular arrhythmias after myocardial infarction: Evidence from the CAPRICORN study (abstr 3303)","volume":"104","author":"McMurray","year":"2001","journal-title":"Circulation"},{"key":"10.1002\/clc.4960281306-BIB31|cit33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.0000108928.25690.94","article-title":"Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: The CAPRICORN Echo Substudy","volume":"109","author":"Doughty","year":"2004","journal-title":"Circulation"},{"issue":"suppl B","key":"10.1002\/clc.4960281306-BIB32|cit34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/eurheartj\/17.suppl_B.8","article-title":"Cardiac adrenergic receptor effects of carvedilol","volume":"17","author":"Yoshikawa","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1002\/clc.4960281306-BIB33|cit35","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1161\/01.CIR.94.11.2817","article-title":"Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart","volume":"94","author":"Gilbert","year":"1996","journal-title":"Circulation"},{"key":"10.1002\/clc.4960281306-BIB34|cit36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): Randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB35|cit37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(85)91900-2","article-title":"Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion","volume":"1","author":"Dornhorst","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB36|cit38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0895-7061(03)00062-1","article-title":"Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control","volume":"16","author":"Holzgreve","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1002\/clc.4960281306-BIB37|cit39","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs. metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1002\/clc.4960281306-BIB38|cit40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0735-1097(96)00489-5","article-title":"Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators","volume":"29","author":"Vantrimpont","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 4","key":"10.1002\/clc.4960281306-BIB39|cit41","doi-asserted-by":"crossref","first-page":"IV14","DOI":"10.1136\/hrt.82.2008.iv14","article-title":"Major beta blocker mortality trials in chronic heart failure: A critical review","volume":"82","author":"McMurray","year":"1999","journal-title":"Heart"},{"key":"10.1002\/clc.4960281306-BIB40|cit42","first-page":"57","article-title":"Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group","volume":"2","author":"ISIS-1 Collaborative Group","year":"1986","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB41|cit43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/oxfordjournals.eurheartj.a061845","article-title":"Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group","volume":"6","author":"MIAMI Trial Research Group","year":"1985","journal-title":"Eur Heart J"},{"key":"10.1002\/clc.4960281306-BIB42|cit44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/204748730000700608","article-title":"Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): A randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction","volume":"7","author":"Second Chinese Cardiac Study (CCS-2) Collaborative Group","year":"2000","journal-title":"J Cardiovasc Risk"},{"key":"10.1002\/clc.4960281306-BIB43|cit45","first-page":"303","article-title":"COMMITT\/CCS-2 (Clopidogrel & Metoprolol in Myocardial Infarction Trial\/Second Chinese Cardiac Study 2005)","volume":"28","author":"Collins","year":"2005","journal-title":"Clin Cardiol"},{"key":"10.1002\/clc.4960281306-BIB44|cit46","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198808183190701","article-title":"The effect of diltiazem on mortality and reinfarction after myocardial infarction","volume":"319","author":"The Multicenter Diltiazem Postinfarction Trial Research Group","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB45|cit47","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0002-9149(96)00860-0","article-title":"Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group","volume":"79","author":"Hansen","year":"1997","journal-title":"Am J Cardiol"},{"issue":"suppl 1","key":"10.1002\/clc.4960281306-BIB46|cit48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-199200441-00007","article-title":"Secondary prevention with calcium antagonists after acute myocardial infarction","volume":"44","author":"Hansen","year":"1992","journal-title":"Drugs"},{"key":"10.1002\/clc.4960281306-BIB47|cit49","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0735-1097(95)00599-4","article-title":"Myocardial infarction patients in the 1990s-their risk factors, stratification and survival in Canada: The Canadian Assessment of Myocardial Infarction (CAMI) Study","volume":"27","author":"Rouleau","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/clc.4960281306-BIB48|cit50","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"J Am Med Assoc"},{"key":"10.1002\/clc.4960281306-BIB49|cit51","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1532-5415.1995.tb07393.x","article-title":"Long-term survival and use of antihypertensive medications in older persons","volume":"43","author":"Pahor","year":"1995","journal-title":"J Am Geriatr Soc"},{"key":"10.1002\/clc.4960281306-BIB50|cit52","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1002\/clc.4960281306-BIB51|cit53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-5273(01)00576-9","article-title":"Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion","volume":"82","author":"Bickel","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1002\/clc.4960281306-BIB52|cit54","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-139-8-200310210-00011","article-title":"Effects of statins on nonlipid serum markers associated with cardiovascular disease: A systematic review","volume":"139","author":"Balk","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1002\/clc.4960281306-BIB53|cit55","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs. a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1002\/clc.4960281306-BIB54|cit56","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.amjcard.2004.10.016","article-title":"Effect of early initiation of statins on survival in patients with acute myocardial infarction (the USIC 2000 Registry)","volume":"95","author":"Ferrieres","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1002\/clc.4960281306-BIB55|cit57","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial","volume":"354","author":"Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB56|cit58","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","article-title":"Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1002\/clc.4960281306-BIB57|cit59","first-page":"I23","article-title":"Recommendations for secondary prevention after myocardial infarction","volume":"93","author":"Arntz","year":"2004","journal-title":"Z. Kardiol"},{"key":"10.1002\/clc.4960281306-BIB58|cit60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"The SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB59|cit61","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","author":"MERIT-HF Investigators","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB60|cit62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial","volume":"353","author":"CIBIS-II Investigators","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/clc.4960281306-BIB61|cit63","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960281306-BIB62|cit64","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.4960281306","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/clc.4960281306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T22:41:27Z","timestamp":1625179287000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.4960281306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,18]]},"references-count":64,"journal-issue":{"issue":"S1"},"URL":"https:\/\/doi.org\/10.1002\/clc.4960281306","relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,18]]}}}